FIELD: medicine.
SUBSTANCE: method involves introducing means containing heavy elements into tumor and expose it to X-ray radiation. A heavy chemical element having number of 53, 55-83 is used. The means contains one or several of said elements with additional ligand introduced as iminodiacetic acid or its derivatives or crownethers or porphyrins and a water-soluble polymer. The means is introduced in systemic or direct way into tumor with following X-ray irradiation of power of 10-200 keV being applied.
EFFECT: increased photon therapy dose concentrated in tumor tissue with concurrently reduced radiation exposure upon the unaffected tissues.
4 cl, 4 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PHOTON CAPTURE THERAPY OF TUMOURS | 2013 |
|
RU2533267C1 |
MEDICINAL CONTRAST COMPOSITION | 2016 |
|
RU2639390C2 |
PREPARATION FOR APPLICATION IN PHOTON CAPTURE THERAPY OF MALIGNANT SOLID NEOPLASMS | 2015 |
|
RU2611379C1 |
METHOD FOR DETERMINING NEUTRON- CAPTURING ONCOLOGICAL PREPARATIONS EFFECTIVENESS IN EXPERIMENTS | 1998 |
|
RU2144669C1 |
METHOD OF PROTON THERAPY FOR SOLID EHRLICH CARCINOMA | 2023 |
|
RU2808984C1 |
GADOPENTETATE-MODIFIED BETA-CYCLODEXTRIN DERIVATIVES | 2013 |
|
RU2541090C1 |
METHOD OF TUMOUR CELLS PROLIFERATION INHIBITION | 2006 |
|
RU2326707C1 |
METHOD FOR TREATING EHRLICH ADENOCARCINOMA BY MEANS OF RADIATION THERAPY | 2021 |
|
RU2781902C1 |
METHOD OF REDUCING TUMOR CELL VIABILITY | 2022 |
|
RU2799517C1 |
METHOD FOR AMPLIFYING ANTITUMORAL EFFECT OF EXPERIMENTAL RADIOTHERAPY | 1993 |
|
RU2044545C1 |
Authors
Dates
2006-02-20—Published
2004-06-24—Filed